Louisiana 2020 Regular Session

Louisiana Senate Bill SB242

Introduced
2/27/20  
Refer
2/27/20  
Refer
2/27/20  
Refer
3/9/20  

Caption

Provides for Litigation Reduction Act. (1/1/21)

Impact

The bill's amendments to the Code of Civil Procedure include lowering the threshold for obtaining a jury trial from $50,000 to $20,000. Proponents of this change argue that it makes the judicial process more accessible to individuals with smaller claims, enabling them to seek justice without the burden of excessive costs. This could potentially increase the number of cases that reach trial, thereby supporting the rights of individuals with less financial means. However, there are concerns that this might lead to an increase in frivolous lawsuits that could overwhelm the court system.

Summary

Senate Bill 242, also known as the Litigation Reduction Act, aims to streamline civil procedures by adjusting the prescriptive periods for delictual actions and modifying the thresholds for jury trials. Effective from January 1, 2021, the bill proposes to extend the general prescriptive period for delictual actions from one year to two years. This change is intended to allow individuals more time to initiate civil claims after experiencing damages. However, it retains the existing three-year prescription period for sexual assault-related cases, maintaining protections for certain vulnerable populations like minors.

Sentiment

The sentiment surrounding SB 242 seems to be mixed. Supporters commend the bill for promoting accessibility to the legal system and providing broader opportunities for individuals seeking recourse for damages. Conversely, critics caution against the reduced threshold for jury trials, expressing fears that it may open the floodgates for minor claims that could clutter courts. This reflects a broader debate over balancing access to justice and maintaining the efficiency and integrity of the legal process.

Contention

One notable point of contention involves the balance between increasing access to civil justice and the potential impact on the judicial system. Opponents of the changes may argue that a lower threshold for jury trials could bog down the court system, complicating the resolution of serious claims. Furthermore, while extending the prescriptive period is seen as a positive step by some, others are concerned about the implications this has for defendants who may face delayed claims as a result. Overall, the Litigation Reduction Act represents a significant shift in civil procedure law with both potential benefits and drawbacks.

Companion Bills

No companion bills found.

Previously Filed As

LA SB3

Provides for the Litigation Reduction Act. (1/1/21) (OR SEE FISC NOTE GF EX)

LA SB418

Enacts the Omnibus Premium Reduction Act of 2020. (1/1/21) (RE1 SEE FISC NOTE SG EX See Note)

LA HB9

Enacts the Omnibus Premium Reduction Act of 2020 (EG SEE FISC NOTE SG EX See Note)

LA HB66

Enacts the Citizens' Premium Reduction Act (Item #40) (EG SEE FISC NOTE GF EX)

LA HB44

Enacts the Omnibus Premium Reduction Act of 2020 (Item #40) (RE SEE FISC NOTE GF EX)

LA HB372

Enacts the Omnibus Premium Reduction Act of 2019 (RE INCREASE GF EX See Note)

LA HB42

Enacts the Omnibus Premium Reduction Act of 2020 (Item #40)

LA HB43

Makes revisions to the Omnibus Premium Reduction Act of 2020 (Item #40)

LA SB241

Extends prescriptive period for delictual actions from one to two years, but except medical malpractice. (1/1/21)

LA SB154

Provides relative to certain civil liability damages and prescription. (8/1/19)

Similar Bills

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA AB852

Health care practitioners: electronic prescriptions.

CA AB149

Controlled substances: prescriptions.

TX HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.